None
Quote | Millendo Therapeutics (NASDAQ:MLND)
Last: | $1.06 |
---|---|
Change Percent: | -5.36% |
Open: | $1.12 |
Close: | $1.06 |
High: | $1.13 |
Low: | $1.06 |
Volume: | 1,832,901 |
Last Trade Date Time: | 06/25/2021 04:42:54 am |
News | Millendo Therapeutics (NASDAQ:MLND)
Gainers: Entera Bio (ENTX) +56%. Orphazyme (ORPH) +47%. Bellerophon Therapeutics (BLPH) +26%. HUTCHMED (HCM) +11%. Evaxion Biotech (EVAX) +8%.Losers: Gemini Therapeutics (GMTX) -32%. Second Sight Medical Products (EYES) -19%. Millendo Therapeutics (MLND) -17...
Gemini Therapeutics (GMTX) -31% after initial data from mid-stage GEM103 AMD study.Second Sight Medical Products (EYES) -18% after secures $50M capital via equity raiseTorchlight Energy Resources (TRCH) -17%.Alfi (ALF) -16% stock pulls back from buyback-fueled ra...
Message Board Posts | Millendo Therapeutics (NASDAQ:MLND)
Subject | By | Source | When |
---|---|---|---|
Looking good so far... | Eurotradr | investorshub | 06/24/2021 1:40:50 PM |
Adding here for the bounce. | Eurotradr | investorshub | 06/24/2021 1:37:50 PM |
Sitting in an oversold position. Let's see the | Eurotradr | investorshub | 06/24/2021 1:37:10 PM |
Time for a reversal and bounce off the | Eurotradr | investorshub | 06/23/2021 1:09:14 PM |
Something really could happen here soon. Course will | Schnatzi | investorshub | 05/04/2021 2:03:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Millendo Therapeutics Company Name:
MLND Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Mille...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.93, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Over the past year, Millendo Therapeutics Inc. has traded in...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.97, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Millendo Therapeutics Inc is a late-stage biopharmaceutical ...